scholarly article | Q13442814 |
P819 | ADS bibcode | 2013PLoSO...875885T |
P356 | DOI | 10.1371/JOURNAL.PONE.0075885 |
P932 | PMC publication ID | 3787937 |
P698 | PubMed publication ID | 24098737 |
P5875 | ResearchGate publication ID | 257465165 |
P2093 | author name string | Ling Tian | |
Jin-zhong Chen | |||
Jing-lun Xue | |||
Yu-xiang Fang | |||
P2860 | cites work | Global cancer statistics | Q22241238 |
Clinical outcome prediction by microRNAs in human cancer: a systematic review | Q24289183 | ||
MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN | Q24597730 | ||
Tumor-specific expression of microRNA-26a suppresses human hepatocellular carcinoma growth via cyclin-dependent and -independent pathways | Q24624119 | ||
A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? | Q24629627 | ||
MicroRNA expression, survival, and response to interferon in liver cancer | Q24647241 | ||
miR-19 is a key oncogenic component of mir-17-92 | Q24652326 | ||
Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model | Q24655262 | ||
The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo | Q24657924 | ||
Molecular pathology of prostate cancer | Q24672410 | ||
Cancer statistics, 2012 | Q27860574 | ||
The phosphoinositide 3-kinase pathway | Q27860738 | ||
Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets | Q27860792 | ||
MicroRNAs: small RNAs with a big role in gene regulation | Q27860896 | ||
MicroRNA expression profiles classify human cancers | Q28032481 | ||
MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice | Q28115423 | ||
Flow-Dependent Regulation of Kruppel-Like Factor 2 Is Mediated by MicroRNA-92a | Q28115981 | ||
Site-specific microRNA-92a regulation of Kruppel-like factors 4 and 2 in atherosusceptible endothelium | Q28116272 | ||
The biology and clinical relevance of the PTEN tumor suppressor pathway | Q28272157 | ||
mir-17-92, a cluster of miRNAs in the midst of the cancer network | Q28275929 | ||
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism | Q29547302 | ||
MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer | Q29547523 | ||
The functions and regulation of the PTEN tumour suppressor | Q29615536 | ||
Targeting PI3K signalling in cancer: opportunities, challenges and limitations | Q29617685 | ||
Role of microRNA-23b in flow-regulation of Rb phosphorylation and endothelial cell growth | Q33733879 | ||
Phosphoinositide 3-kinase pathway activation in phosphate and tensin homolog (PTEN)-deficient prostate cancer cells is independent of receptor tyrosine kinases and mediated by the p110beta and p110delta catalytic subunits | Q33832537 | ||
STAT3 Activation of miR-21 and miR-181b-1 via PTEN and CYLD Are Part of the Epigenetic Switch Linking Inflammation to Cancer | Q34088885 | ||
Identification of the miR-106b~25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation | Q34109986 | ||
Costimulation-dependent expression of microRNA-214 increases the ability of T cells to proliferate by targeting Pten. | Q34416068 | ||
microRNA-92a promotes lymph node metastasis of human esophageal squamous cell carcinoma via E-cadherin | Q34695995 | ||
Cell autonomous role of PTEN in regulating castration-resistant prostate cancer growth | Q35168294 | ||
Class IA phosphoinositide 3-kinases are obligate p85-p110 heterodimers | Q35808718 | ||
Molecular biology of prostate-cancer pathogenesis | Q36470685 | ||
microRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN | Q36642781 | ||
Tenets of PTEN tumor suppression | Q37154214 | ||
MicroRNA-based therapeutics for cancer | Q37432033 | ||
PI(3)king apart PTEN's role in cancer. | Q37771785 | ||
The emerging important role of microRNAs in the pathogenesis, diagnosis and treatment of human cancers. | Q37923731 | ||
Prostate cancer overview | Q37948306 | ||
Posttranscriptional regulation of PTEN dosage by noncoding RNAs | Q39287302 | ||
Role of miR-19b and its target mRNAs in 5-fluorouracil resistance in colon cancer cells. | Q39387335 | ||
Genome-wide functional screening of miR-23b as a pleiotropic modulator suppressing cancer metastasis | Q39438566 | ||
miR-92 is a key oncogenic component of the miR-17-92 cluster in colon cancer | Q39480964 | ||
MicroRNA-221 and -222 regulate radiation sensitivity by targeting the PTEN pathway | Q39560767 | ||
miR‐125b promotes growth of prostate cancer xenograft tumor through targeting pro‐apoptotic genes | Q39649207 | ||
MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC). | Q39728869 | ||
Transcriptional and translational dual-regulated oncolytic herpes simplex virus type 1 for targeting prostate tumors | Q39735950 | ||
Development of chimeric gene regulators for cancer-specific gene therapy with both transcriptional and translational targeting | Q39747000 | ||
MicroRNA-23b cluster microRNAs regulate transforming growth factor-beta/bone morphogenetic protein signaling and liver stem cell differentiation by targeting Smads. | Q39828166 | ||
MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells. | Q39843898 | ||
MicroRNA-22 promotes cell survival upon UV radiation by repressing PTEN. | Q40434551 | ||
A new human prostate carcinoma cell line, 22Rv1. | Q40933318 | ||
Recurrent cytogenetic alterations of prostate carcinoma and amplification of c-myc or epidermal growth factor receptor in subclones of immortalized PNT1 human prostate epithelial cell line. | Q41295367 | ||
Establishment and characterization of an immortalized but non-transformed human prostate epithelial cell line: BPH-1. | Q41404265 | ||
Functional expression of sv40 in normal human prostatic epithelial and fibroblastic cells - differentiation pattern of nontumorigenic cell-lines. | Q42816598 | ||
Frequent inactivation of PTEN in prostate cancer cell lines and xenografts | Q47855108 | ||
Diagnostic potential of PTEN-targeting miR-214 in the blood of breast cancer patients. | Q53659259 | ||
MicroRNAs and prostate cancer | Q57140772 | ||
Overexpression of cyclin D1 is associated with metastatic prostate cancer to bone | Q61510111 | ||
The LNCaP cell line--a new model for studies on human prostatic carcinoma | Q71222674 | ||
MicroRNA-21 promotes the cell proliferation, invasion and migration abilities in ovarian epithelial carcinomas through inhibiting the expression of PTEN protein | Q82270543 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | microRNA | Q310899 |
P304 | page(s) | e75885 | |
P577 | publication date | 2013-09-30 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Four microRNAs promote prostate cell proliferation with regulation of PTEN and its downstream signals in vitro | |
P478 | volume | 8 |
Q38866081 | A Pitx2-MicroRNA Pathway Modulates Cell Proliferation in Myoblasts and Skeletal-Muscle Satellite Cells and Promotes Their Commitment to a Myogenic Cell Fate. |
Q41039911 | A randomized double-blind placebo controlled phase I-II study on clinical and molecular effects of dietary supplements in men with precancerous prostatic lesions. Chemoprevention or "chemopromotion"? |
Q90570508 | Alternative polyadenylation confers Pten mRNAs stability and resistance to microRNAs |
Q36396552 | CancerNet: a database for decoding multilevel molecular interactions across diverse cancer types |
Q36053185 | Comparative Study of Extracellular Vesicles from the Urine of Healthy Individuals and Prostate Cancer Patients |
Q38242086 | Current clinical regulation of PI3K/PTEN/Akt/mTOR signalling in treatment of human cancer |
Q42114708 | DGCR8 is essential for tumor progression following PTEN loss in the prostate |
Q89868682 | Downregulation of miR-193a-3p is involved in the pathogenesis of hepatocellular carcinoma by targeting CCND1 |
Q38695486 | Effects of naringin on the expression of miR-19b and cell apoptosis in human hepatocellular carcinoma |
Q26797287 | Focus on PTEN Regulation |
Q38862245 | Function of extracellular vesicle-associated miRNAs in metastasis |
Q36875837 | Green tea and quercetin sensitize PC-3 xenograft prostate tumors to docetaxel chemotherapy |
Q36335722 | IL-15 regulates migration, invasion, angiogenesis and genes associated with lipid metabolism and inflammation in prostate cancer |
Q92839451 | Irisin attenuates H2O2-induced apoptosis in cardiomyocytes via microRNA-19b/AKT/mTOR signaling pathway |
Q90092821 | Long non-coding RNA FER1L4 inhibits prostate cancer progression via sponging miR-92a-3p and upregulation of FBXW7 |
Q38736898 | Loss of miR-26a-5p promotes proliferation, migration, and invasion in prostate cancer through negatively regulating SERBP1. |
Q38725879 | MiR-200a acts as an oncogene in colorectal carcinoma by targeting PTEN. |
Q38750019 | MiR-26a and miR-138 block the G1/S transition by targeting the cell cycle regulating network in prostate cancer cells. |
Q54200488 | MiR-26a inhibits prostate cancer progression by repression of Wnt5a. |
Q39470921 | MiR-92a regulates viability and angiogenesis of endothelial cells under oxidative stress. |
Q37113174 | MicroRNA expression and function in prostate cancer: a review of current knowledge and opportunities for discovery |
Q35510445 | MicroRNA in prostate cancer: functional importance and potential as circulating biomarkers |
Q55227135 | MicroRNA-126 inhibits proliferation and metastasis in prostate cancer via regulation of ADAM9. |
Q36202394 | MicroRNA-17-5p induces drug resistance and invasion of ovarian carcinoma cells by targeting PTEN signaling |
Q45849909 | MicroRNA-193a-3p inhibits cell proliferation in prostate cancer by targeting cyclin D1. |
Q92837703 | MicroRNA-21-5p antagonizes oxidant-mediated apoptosis in alveolar epithelial type II cells by targeting PDCD4 |
Q90707597 | MicroRNA-26b/PTEN Signaling Pathway Mediates Glycine-Induced Neuroprotection in SAH Injury |
Q35190448 | MicroRNA-92a inhibition attenuates hypoxia/reoxygenation-induced myocardiocyte apoptosis by targeting Smad7. |
Q38205266 | MicroRNAs and drug resistance in prostate cancers |
Q36520345 | MicroRNA‑126 inhibits proliferation and metastasis by targeting pik3r2 in prostate cancer |
Q38668635 | Molecular biomarkers to guide precision medicine in localized prostate cancer |
Q32179591 | Overexpression of miRNA-221 promotes cell proliferation by targeting the apoptotic protease activating factor-1 and indicates a poor prognosis in ovarian cancer |
Q47140618 | PTEN-Dependent Stabilization of MTSS1 Inhibits Metastatic Phenotype in Pancreatic Ductal Adenocarcinoma |
Q42748239 | Prognostic value of ERG, PTEN, CRISP3 and SPINK1 in predicting biochemical recurrence in prostate cancer |
Q42314673 | Redox Regulating Enzymes and Connected MicroRNA Regulators Have Prognostic Value in Classical Hodgkin Lymphomas |
Q28608111 | Registered report: A coding-independent function of gene and pseudogene mRNAs regulates tumour biology |
Q92110215 | Replication Study: A coding-independent function of gene and pseudogene mRNAs regulates tumour biology |
Q64239667 | Role of microRNA-92a in metastasis of osteosarcoma cells in vivo and in vitro by inhibiting expression of TCF21 with the transmission of bone marrow derived mesenchymal stem cells |
Q39044222 | Somatic Mutations in Prostate Cancer: Closer to Personalized Medicine. |
Q26776527 | The PTEN tumor suppressor gene and its role in lymphoma pathogenesis |
Q34091442 | The impact of microRNA-mediated PI3K/AKT signaling on epithelial-mesenchymal transition and cancer stemness in endometrial cancer |
Q38258638 | The miRNA23b-regulated signaling network as a key to cancer development--implications for translational research and therapeutics |
Q38859577 | The roles of microRNAs in the progression of castration-resistant prostate cancer |
Q36153397 | Up-regulation of microRNA-491-5p suppresses cell proliferation and promotes apoptosis by targeting FOXP4 in human osteosarcoma. |
Q35038714 | Upregulation of microRNA-23a/b promotes tumor progression and confers poor prognosis in patients with gastric cancer |
Q36998116 | miR-19b attenuates H2O2-induced apoptosis in rat H9C2 cardiomyocytes via targeting PTEN |
Q90429370 | miR-19b serves as a prognostic biomarker of breast cancer and promotes tumor progression through PI3K/AKT signaling pathway |
Q93111596 | miR-23b and miR-27b are oncogenic microRNAs in breast cancer: evidence from a CRISPR/Cas9 deletion study |
Q35176071 | miR-26a and miR-214 down-regulate expression of the PTEN gene in chronic lymphocytic leukemia, but not PTEN mutation or promoter methylation |